PharmaCorp Rx Operating Expenses

Total Operating Expenses of PharmaCorp Rx is 3.77 M CAD in 2026.

Total Operating Expenses of PharmaCorp Rx changed from 578,000.00 CAD to 3.77 M CAD, representing a 552.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Operating Expenses PharmaCorp Rx since 2006 – with annual values, charts, and detailed analysis.

Operating expenses are the costs incurred in the normal course of business operations, including COGS, SG&A, R&D, and depreciation.

Total Operating Expenses's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Operating Expenses's PharmaCorp Rx historically and in real time.